Evidence map›Paper›PMID 38198529›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Minimal requirements for the epigenetic inheritance of engineered silent chromatin domains.

Andy H Yuan, Danesh Moazed

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andy H YuanHHMI, Harvard Medical School, Boston, MA 02115.
Danesh MoazedHHMI, Harvard Medical School, Boston, MA 02115.
Boston VA Research Institute · US

Funding

RNAi-mediated Targeting of Hetorochromatin AssemblyR01GM072805 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MOAZED, DANESH · 2005 to 2025
$6.9M
Reconstitution of heterochromatin and gene silencing in vivoK99GM137045 · NIGMS · HARVARD MEDICAL SCHOOL · PI YUAN, ANDY · 2020 to 2021
$200k
Reconstituting heterochromatin and gene silencing in vivoF32GM131438 · NIGMS · HARVARD MEDICAL SCHOOL · PI YUAN, ANDY · 2019 to 2020
$79k
NIGMS NIH HHS F32 GM131438NIGMS NIH HHS K99 GM137045NIGMS NIH HHS R01 GM072805
6 · The paper itself

Abstract

Mechanisms enabling genetically identical cells to differentially regulate gene expression are complex and central to organismal development and evolution. While gene silencing pathways involving DNA sequence-specific recruitment of histone-modifying enzymes are prevalent in nature, examples of sequence-independent heritable gene silencing are scarce. Studies of the fission yeast

Indexed as

ChromatinLysineGene SilencingHeterochromatinHistonesChromatinHeterochromatinHistonesLysineepigenetic inheritanceheterochromatinhistone deacetylationHP1SIR complex

Identifiers

PMID38198529
PMCPMC10801849
OpenAlexW4390691791

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.